Evidence map›Paper›PMID 24343049›Full record

ArticleHuman vaccines & immunotherapeutics2014

Effectiveness of 2012-2013 influenza vaccine against influenza-like illness in general population: estimation in a French web-based cohort.

Marion Debin, Vittoria Colizza, Thierry Blanchon, Thomas Hanslik, Clement Turbelin, Alessandra Falchi

Open access · bronzeAbstract read
In one paragraph

Article in Human vaccines & immunotherapeutics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Observational
  4. Participatory Disease Surveillance Systems: Ethical Framework.Journal of medical Internet research · 2019
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 4 countries.

Marion DebinInstitut National de la Santé et de la Recherche Médicale; Paris, France; Université Pierre et Marie Curie-Paris 6; Paris, France.
Vittoria ColizzaInstitut National de la Santé et de la Recherche Médicale; Paris, France; Université Pierre et Marie Curie-Paris 6; Paris, France; Institute for Scientific Interchange; Torino, Italy.
Thierry BlanchonInstitut National de la Santé et de la Recherche Médicale; Paris, France; Université Pierre et Marie Curie-Paris 6; Paris, France.
Thomas HanslikInstitut National de la Santé et de la Recherche Médicale; Paris, France; Université Pierre et Marie Curie-Paris 6; Paris, France; Université Versailles Saint Quentin en Yvelines; Versailles, France; Assistance Publique Hopitaux de Paris; Hopital Ambroise Paré; Boulogne Billancourt, France.
Clement TurbelinInstitut National de la Santé et de la Recherche Médicale; Paris, France; Université Pierre et Marie Curie-Paris 6; Paris, France.
Alessandra FalchiInstitut National de la Santé et de la Recherche Médicale; Paris, France; Université de Corse; Laboratoire de Virologie; Corte, France.
Institut National de Recherche en Santé Publique · MLSorbonne Université · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Most of the methods used for estimating the influenza vaccine effectiveness (IVE) target the individuals who have an influenza-like illness (ILI) rather than virologically-proven influenza and access the healthcare system. The objective of this study was to estimate the 2012-2013 IVE in general French population, using a cohort of volunteers registered on GrippeNet.fr, an online surveillance system for ILI. The IVE estimations were obtained through a logistic regression, and analyses were also performed by focusing on at-risk population of severe influenza, and by varying inclusion period and ILI definition. Overall, 1996 individuals were included in the analyses. The corrected IVE was estimated to 49% (20 to 67) for the overall population, and 32% (0 to 58) for the at-risk population. Three covariables appeared with a significant effect on the occurrence of at least one ILI during the epidemic: the age (P = 0.045), the presence of a child in the household (P<10(-3)), and the frequency of cold/flu (P<10(-3)). Comparable results were found at epidemic peak time in the hypothesis of real-time feed of data. In this study, we proposed a novel, follow-up, web-based method to reveal seasonal vaccine effectiveness, which enables analysis in a portion of the population that is not tracked by the health care system in most VE studies.

Indexed as

Epidemiological MonitoringAdolescentAdultAgedAged, 80 and overChildChild, PreschoolCohort StudiesFemaleFollow-Up StudiesFranceHumansIncidenceInfantInfant, NewbornInfluenza, HumanInfluenza Vaccinesgeneral populationGrippeNetinfluenzavaccinevaccine effectiveness

Identifiers

PMID24343049
PMCPMC4130275
OpenAlexW1979695060

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.